Castle Biosciences Presents New Data at ASTRO 2023 Highlighting Risk-Stratification Performance of DecisionDx®-SCC in Patients with Cutaneous Squamous Cell Carcinoma Eligible for Adjuvant Radiation Therapy
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Oct 3, 2023--
Source: eagletribune.com